A drug discovery programme against COVID-19
The COVID-19 pandemic has highlighted the lack of vaccines and drugs to tackle this health emergency. Scientists of the EU-funded SCORE project have previously worked to understand and inhibit coronavirus replication, unveiling key viral functions and developing appropriate tools for screening and identifying drug candidates. The project will build on this expertise to establish a state-of-the-art drug discovery approach for inhibitors active against evolving 2019-nCoV strains. Researchers will test already approved antivirals and design new ones that target virus entry into the cell, RNA replication and protein function. Preliminary results are expected within six to nine months, and selected compounds will be forwarded for development.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action